OA-29 First-Year Results of Isatuximab–Iberdomide Maintenance in MRD-Positive Newly Diagnosed Multiple Myeloma Patients Included in the Phase 3 MIDAS Trial
Year: 2026
Type: conference-abstract
Authors: Aurore Perrot, Jerome Lambert, Cyrille Hulin, Andrea Pieragostini, Lionel Karlin, Bertrand Arnulf, Philippe Rey, Laurent Garderet, Margaret Macro, Martine Escoffre, Julie Gay, Thomas Chalopin, Romain Gounot, Jean Marc Schiano de Colella, Gedeon Agbetsivi, Mohamad Mohty, Cyrine Ellouz, Jean Fontan, Salomon Manier, Frederique Orsini-Piocelle, Laure Vincent, Xavier Leleu, Jill Corre, Philippe Moreau, Cyrille Touzeau
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7213932244